TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs67138555
log Bayes Factor = 15.4054
Chromosome 10   position 16,461,877  (GRCh37) Explore rs67138555 on Ensembl!
Variant rs67138555 is part of Cluster X0050

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
Chapter II Neoplasms
1.000 0.000 0.000
# Top node
1.000 0.000 0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
1.000 0.000 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.999 0.001 0.000
Chapter X Diseases of the respiratory system
0.999 0.001 0.000
Chapter XIV Diseases of the genitourinary system
0.999 0.001 0.000
Chapter I Certain infectious and parasitic diseases
0.997 0.003 0.000
J40-J47 Chronic lower respiratory diseases
0.995 0.005 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.995 0.005 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.991 0.009 0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.991 0.009 0.000
N17-N19 Renal failure
0.985 0.015 0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.983 0.017 0.000
C78.0 Secondary malignant neoplasm of lung
0.981 0.019 0.000
C83.3 Large cell (diffuse)
0.978 0.022 0.000
Chapter V Mental and behavioural disorders
0.978 0.022 0.000
Chapter VII Diseases of the eye and adnexa
0.977 0.023 0.000
J43 Emphysema
0.976 0.024 0.000
N18 Chronic renal failure
0.968 0.032 0.000
Chapter VI Diseases of the nervous system
0.968 0.032 0.000
C34 Malignant neoplasm of bronchus and lung
0.964 0.036 0.000
N80-N98 Noninflammatory disorders of female genital tract
0.963 0.037 0.000
J43.9 Emphysema, unspecified
0.962 0.038 0.000
J09-J18 Influenza and pneumonia
0.961 0.039 0.000
C79 Secondary malignant neoplasm of other sites
0.960 0.040 0.000
A30-A49 Other bacterial diseases
0.960 0.040 0.000
N81 Female genital prolapse
0.959 0.041 0.000
C15-C26 Malignant neoplasms of digestive organs
0.957 0.043 0.000
D70-D77 Other diseases of blood and blood-forming organs
0.957 0.043 0.000
N92 Excessive, frequent and irregular menstruation
0.956 0.044 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.954 0.046 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.954 0.046 0.000
H00-H06 Disorders of eyelid, lacrimal system and orbit
0.951 0.049 0.000
F17 Mental and behavioural disorders due to use of tobacco
0.947 0.053 0.000
J44 Other chronic obstructive pulmonary disease
0.943 0.057 0.000
A41 Other septicaemia
0.940 0.060 0.000
H04 Disorders of lachrymal system
0.938 0.062 0.000
F17.1 Harmful use
0.936 0.064 0.000
Chapter XIII Diseases of the musculoskeletal system and connective tissue
0.933 0.067 0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
0.925 0.075 0.000
Chapter XX External causes of morbidity and mortality
0.924 0.076 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.924 0.076 0.000
B35-B49 Mycoses
0.923 0.077 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.919 0.081 0.000
A41.9 Septicaemia, unspecified
0.918 0.082 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.918 0.082 0.000
N92.0 Excessive and frequent menstruation with regular cycle
0.917 0.083 0.000
N18.9 Chronic renal failure, unspecified
0.917 0.083 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.916 0.084 0.000
C90.0 Multiple myeloma
0.913 0.087 0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.910 0.090 0.000
J44.9 Chronic obstructive pulmonary disease, unspecified
0.909 0.091 0.000
C18 Malignant neoplasm of colon
0.908 0.092 0.000
N92.6 Irregular menstruation, unspecified
0.907 0.093 0.000
C43-C44 Melanoma and other malignant neoplasms of skin
0.903 0.097 0.000
N60-N64 Disorders of breast
0.902 0.098 0.000
N81.6 Rectocele
0.900 0.100 0.000
C34.9 Bronchus or lung, unspecified
0.898 0.102 0.000
N81.8 Other female genital prolapse
0.893 0.107 0.000
J60-J70 Lung diseases due to external agents
0.892 0.108 0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.890 0.110 0.000
D70 Agranulocytosis
0.889 0.111 0.000
J95-J99 Other diseases of the respiratory system
0.885 0.115 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.884 0.116 0.000
G50-G59 Nerve, nerve root and plexus disorders
0.884 0.116 0.000
H25-H28 Disorders of lens
0.880 0.120 0.000
N70-N77 Inflammatory diseases of female pelvic organs
0.878 0.122 0.000
J80-J84 Other respiratory diseases principally affecting the interstitium
0.878 0.122 0.000
H04.1 Other disorders of lachrymal gland
0.875 0.125 0.000
N18.3 Chronic kidney disease, stage 3
0.872 0.128 0.000
G20-G26 Extrapyramidal and movement disorders
0.872 0.128 0.000
Y43 Primarily systemic agents
0.870 0.130 0.000
G55 Nerve root and plexus compressions in diseases classified elsewhere
0.867 0.133 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.865 0.134 0.000
J18 Pneumonia, organism unspecified
0.865 0.135 0.000
B37 Candidiasis
0.862 0.138 0.000
C44 Other malignant neoplasms of skin
0.860 0.140 0.000
B99-B99 Other infectious diseases
0.856 0.144 0.000
C34.3 Lower lobe, bronchus or lung
0.856 0.144 0.000
N81.4 Uterovaginal prolapse, unspecified
0.856 0.144 0.000
H04.2 Epiphora
0.854 0.146 0.000
M65-M68 Disorders of synovium and tendon
0.854 0.146 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.853 0.147 0.000
D75 Other diseases of blood and blood-forming organs
0.850 0.150 0.000
G80-G83 Cerebral palsy and other paralytic syndromes
0.848 0.152 0.000
N81.1 Cystocele
0.847 0.153 0.000
C18.9 Colon, unspecified
0.846 0.154 0.000
G55.2 Nerve root and plexus compressions in spondylosis
0.845 0.155 0.000
N19 Unspecified renal failure
0.845 0.155 0.000
N89 Other noninflammatory disorders of vagina
0.844 0.156 0.000
B37.0 Candidal stomatitis
0.841 0.159 0.000
C64-C68 Malignant neoplasms of urinary tract
0.840 0.160 0.000
N10-N16 Renal tubulo-interstitial diseases
0.833 0.167 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.831 0.169 0.000
Y43.3 Other antineoplastic drugs
0.831 0.169 0.000
J46 Status asthmaticus
0.830 0.170 0.000
N63 Unspecified lump in breast
0.828 0.172 0.000
F17.2 Dependence syndrome
0.827 0.173 0.000
H25 Senile cataract
0.823 0.177 0.000
D68 Other coagulation defects
0.822 0.178 0.000
G30-G32 Other degenerative diseases of the nervous system
0.821 0.179 0.000
C19 Malignant neoplasm of rectosigmoid junction
0.821 0.179 0.000
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction
0.820 0.180 0.000
J61 Pneumoconiosis due to asbestos and other mineral fibres
0.819 0.181 0.000
C77.1 Intrathoracic lymph nodes
0.818 0.182 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.818 0.182 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.817 0.183 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.815 0.185 0.000
M45-M49 Spondylopathies
0.815 0.185 0.000
J18.0 Bronchopneumonia, unspecified
0.811 0.189 0.000
H05 Disorders of orbit
0.811 0.189 0.000
C77.3 Axillary and upper limb lymph nodes
0.808 0.192 0.000
J42 Unspecified chronic bronchitis
0.808 0.192 0.000
D69 Purpura and other haemorrhagic conditions
0.806 0.194 0.000
C32 Malignant neoplasm of larynx
0.805 0.195 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.805 0.195 0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions
0.804 0.196 0.000
N18.2 Chronic kidney disease, stage 2
0.804 0.196 0.000
M65 Synovitis and tenosynovitis
0.798 0.202 0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system
0.797 0.203 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.796 0.204 0.000
N92.3 Ovulation bleeding
0.796 0.204 0.000
C34.1 Upper lobe, bronchus or lung
0.794 0.206 0.000
N25-N29 Other disorders of kidney and ureter
0.793 0.207 0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.793 0.207 0.000
N73 Other female pelvic inflammatory diseases
0.792 0.208 0.000
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament
0.791 0.209 0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body
0.791 0.209 0.000
C44.0 Skin of lip
0.791 0.209 0.000
M95-M99 Other disorders of the musculoskeletal system and connective tissue
0.791 0.209 0.000
H43-H45 Disorders of vitreous body and globe
0.790 0.210 0.000
C64 Malignant neoplasm of kidney, except renal pelvis
0.789 0.211 0.000
H25.9 Senile cataract, unspecified
0.789 0.211 0.000
C51-C58 Malignant neoplasms of female genital organs
0.788 0.212 0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
0.788 0.212 0.000
C44.4 Skin of scalp and neck
0.786 0.214 0.000
F30-F39 Mood [affective] disorders
0.786 0.214 0.000
J15 Bacterial pneumonia, not elsewhere classified
0.785 0.215 0.000
B15-B19 Viral hepatitis
0.783 0.217 0.000
A00-A09 Intestinal infectious diseases
0.782 0.218 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.781 0.219 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.778 0.222 0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic
0.778 0.222 0.000
B65-B83 Helminthiases
0.776 0.224 0.000
A41.8 Other specified septicaemia
0.775 0.225 0.000
J13 Pneumonia due to Streptococcus pneumoniae
0.774 0.226 0.000
M40-M43 Deforming dorsopathies
0.772 0.228 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.770 0.230 0.000
H04.3 Acute and unspecified inflammation of lachrymal passages
0.768 0.232 0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum
0.768 0.232 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.767 0.233 0.000
N82 Fistulae involving female genital tract
0.766 0.234 0.000
B20-B24 Human immunodeficiency virus [HIV] disease
0.765 0.235 0.000
C45 Mesothelioma
0.765 0.235 0.000
C25 Malignant neoplasm of pancreas
0.764 0.236 0.000
N18.4 Chronic kidney disease, stage 4
0.763 0.237 0.000
D60-D64 Aplastic and other anaemias
0.763 0.237 0.000
F80-F89 Disorders of psychological development
0.762 0.238 0.000
N64 Other disorders of breast
0.759 0.241 0.000
D45 Polycythaemia vera
0.758 0.242 0.000
J11 Influenza, virus not identified
0.758 0.242 0.000
B99 Other and unspecified infectious diseases
0.755 0.245 0.000
C78.2 Secondary malignant neoplasm of pleura
0.755 0.245 0.000
C78.4 Secondary malignant neoplasm of small intestine
0.755 0.245 0.000
B90-B94 Sequelae of infectious and parasitic diseases
0.754 0.246 0.000
N00-N08 Glomerular diseases
0.754 0.246 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.753 0.247 0.000
N86 Erosion and ectropion of cervix uteri
0.753 0.247 0.000
C80 Malignant neoplasm without specification of site
0.752 0.248 0.000
C49 Malignant neoplasm of other connective and soft tissue
0.750 0.250 0.000
M05-M14 Inflammatory polyarthropathies
0.749 0.251 0.000
G20 Parkinson's disease
0.748 0.252 0.000
C21 Malignant neoplasm of anus and anal canal
0.747 0.253 0.000
J81 Pulmonary oedema
0.747 0.253 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.747 0.253 0.000
M80-M85 Disorders of bone density and structure
0.746 0.254 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.746 0.254 0.000
J95 Postprocedural respiratory disorders, not elsewhere classified
0.746 0.254 0.000
A80-A89 Viral infections of the central nervous system
0.745 0.254 0.000
D72 Other disorders of white blood cells
0.745 0.255 0.000
C18.0 Caecum
0.743 0.257 0.000
A50-A64 Infections with a predominantly sexual mode of transmission
0.743 0.257 0.000
C85.1 B-cell lymphoma, unspecified
0.740 0.260 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.740 0.260 0.000
H04.5 Stenosis and insufficiency of lachrymal passages
0.740 0.260 0.000
J40 Bronchitis, not specified as acute or chronic
0.739 0.261 0.000
Chapter XII Diseases of the skin and subcutaneous tissue
0.739 0.261 0.000
C18.2 Ascending colon
0.738 0.262 0.000
C34.0 Main bronchus
0.738 0.262 0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection
0.738 0.262 0.000
J98 Other respiratory disorders
0.737 0.263 0.000
G81 Hemiplegia
0.736 0.264 0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs
0.736 0.264 0.000
G25 Other extrapyramidal and movement disorders
0.736 0.264 0.000
C44.5 Skin of trunk
0.735 0.265 0.000
C78.7 Secondary malignant neoplasm of liver
0.735 0.265 0.000
C90.2 Plasmacytoma, extramedullary
0.734 0.266 0.000
C44.2 Skin of ear and external auricular canal
0.734 0.266 0.000
N73.6 Female pelvic peritoneal adhesions
0.734 0.266 0.000
J10 Influenza due to identified influenza virus
0.731 0.269 0.000
N81.9 Female genital prolapse, unspecified
0.730 0.270 0.000
F60-F69 Disorders of adult personality and behaviour
0.727 0.273 0.000
D75.2 Essential thrombocytosis
0.725 0.275 0.000
N81.5 Vaginal enterocele
0.725 0.275 0.000
F29 Unspecified nonorganic psychosis
0.723 0.277 0.000
C77.8 Lymph nodes of multiple regions
0.721 0.278 0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.721 0.279 0.000
A41.5 Septicaemia due to other Gram-negative organisms
0.720 0.280 0.000
J18.9 Pneumonia, unspecified
0.720 0.280 0.000
G55.1 Nerve root and plexus compressions in intervertebral disk disorders
0.719 0.281 0.000
C81 Hodgkin's disease
0.718 0.282 0.000
M65.3 Trigger finger
0.718 0.282 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.718 0.282 0.000
V40-V49 Car occupant injured in transport accident
0.718 0.282 0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.718 0.282 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.717 0.283 0.000
Chapter XVI Certain conditions originating in the perinatal period
0.717 0.283 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.717 0.283 0.000
Chapter XXII Codes for special purposes
0.717 0.283 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.717 0.283 0.000
C95 Leukaemia of unspecified cell type
0.717 0.283 0.000
C94 Other leukaemias of specified cell type
0.717 0.283 0.000
C93 Monocytic leukaemia
0.717 0.283 0.000
C88 Malignant immunoproliferative diseases
0.717 0.283 0.000
C86 Other specified types of T/NK-cell lymphoma
0.717 0.283 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.717 0.283 0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.716 0.283 0.000
W50-W64 Exposure to animate mechanical forces
0.716 0.284 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.715 0.285 0.000
B85-B89 Pediculosis, acariasis and other infestations
0.715 0.285 0.000
B50-B64 Protozoal diseases
0.715 0.285 0.000
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers
0.715 0.285 0.000
A75-A79 Rickettsioses
0.715 0.285 0.000
A70-A74 Other diseases caused by chlamydiae
0.715 0.285 0.000
A65-A69 Other spirochaetal diseases
0.715 0.285 0.000
A20-A28 Certain zoonotic bacterial diseases
0.715 0.285 0.000
A15-A19 Tuberculosis
0.715 0.285 0.000
B25-B34 Other viral diseases
0.714 0.286 0.000
D50-D53 Nutritional anaemias
0.714 0.286 0.000
J41 Simple and mucopurulent chronic bronchitis
0.713 0.286 0.000
J80 Adult respiratory distress syndrome
0.713 0.287 0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.713 0.287 0.000
C78.1 Secondary malignant neoplasm of mediastinum
0.713 0.287 0.000
D55-D59 Haemolytic anaemias
0.713 0.287 0.000
D68.0 Von Willebrand's disease
0.712 0.288 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.712 0.288 0.000
N60 Benign mammary dysplasia
0.711 0.289 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.710 0.290 0.000
C83.7 Burkitt's tumour
0.710 0.290 0.000
C83.6 Undifferentiated (diffuse)
0.710 0.290 0.000
C83.5 Lymphoblastic (diffuse)
0.710 0.290 0.000
C83.4 Immunoblastic (diffuse)
0.710 0.290 0.000
C83.2 Mixed small and large cell (diffuse)
0.710 0.290 0.000
C83.1 Small cleaved cell (diffuse)
0.710 0.290 0.000
C83.0 Small cell (diffuse)
0.710 0.290 0.000
H46-H48 Disorders of optic nerve and visual pathways
0.710 0.290 0.000
N89.9 Noninflammatory disorder of vagina, unspecified
0.710 0.290 0.000
M60-M63 Disorders of muscles
0.708 0.292 0.000
C18.1 Appendix
0.706 0.294 0.000
N40-N51 Diseases of male genital organs
0.706 0.294 0.000
F00-F09 Organic, including symptomatic, mental disorders
0.706 0.294 0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
0.705 0.295 0.000
C38 Malignant neoplasm of heart, mediastinum and pleura
0.705 0.295 0.000
C31 Malignant neoplasm of accessory sinuses
0.705 0.295 0.000
C30 Malignant neoplasm of nasal cavity and middle ear
0.705 0.295 0.000
C37 Malignant neoplasm of thymus
0.705 0.295 0.000
C33 Malignant neoplasm of trachea
0.705 0.295 0.000
F12 Mental and behavioural disorders due to use of cannabinoids
0.701 0.299 0.000
H25.0 Senile incipient cataract
0.701 0.299 0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.701 0.299 0.000
F70-F79 Mental retardation
0.701 0.299 0.000
D75.9 Disease of blood and blood-forming organs, unspecified
0.701 0.299 0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
0.701 0.299 0.000
J43.8 Other emphysema
0.700 0.300 0.000
J43.2 Centrilobular emphysema
0.700 0.300 0.000
J43.1 Panlobular emphysema
0.700 0.300 0.000
J43.0 MacLeod's syndrome
0.700 0.300 0.000
G51 Facial nerve disorders
0.699 0.301 0.000
H49 Paralytic strabismus
0.698 0.302 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.696 0.304 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.696 0.304 0.000
H50 Other strabismus
0.695 0.305 0.000
G35-G37 Demyelinating diseases of the central nervous system
0.694 0.305 0.000
N18.8 Other chronic renal failure
0.694 0.306 0.000
N18.1 Chronic kidney disease, stage 1
0.694 0.306 0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.694 0.306 0.000
A08 Viral and other specified intestinal infections
0.693 0.307 0.000
D80-D89 Certain disorders involving the immune mechanism
0.693 0.307 0.000
B35 Dermatophytosis
0.692 0.308 0.000
C34.8 Overlapping lesion of bronchus and lung
0.691 0.309 0.000
C34.2 Middle lobe, bronchus or lung
0.691 0.309 0.000
M48 Other spondylopathies
0.691 0.309 0.000
N98 Complications associated with artificial fertilisation
0.691 0.309 0.000
N91 Absent, scanty and rare menstruation
0.691 0.309 0.000
N96 Habitual aborter
0.691 0.309 0.000
Y95 Nosocomial condition
0.691 0.309 0.000
B02 Zoster [herpes zoster]
0.690 0.310 0.000
D62 Acute posthaemorrhagic anaemia
0.690 0.310 0.000
J17 Pneumonia in diseases classified elsewhere
0.689 0.311 0.000
J16 Pneumonia due to other infectious organisms, not elsewhere classified
0.689 0.311 0.000
J12 Viral pneumonia, not elsewhere classified
0.689 0.311 0.000
J14 Pneumonia due to Haemophilus influenzae
0.689 0.311 0.000
J09 Influenza due to certain identified influenza virus
0.689 0.311 0.000
C56 Malignant neoplasm of ovary
0.689 0.311 0.000
N92.4 Excessive bleeding in the premenopausal period
0.689 0.311 0.000
C79.6 Secondary malignant neoplasm of ovary
0.689 0.311 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.689 0.311 0.000
G00-G09 Inflammatory diseases of the central nervous system
0.689 0.311 0.000
A48 Other bacterial diseases, not elsewhere classified
0.688 0.312 0.000
A44 Bartonellosis
0.688 0.312 0.000
A43 Nocardiosis
0.688 0.312 0.000
A42 Actinomycosis
0.688 0.312 0.000
A40 Streptococcal septicaemia
0.688 0.312 0.000
A39 Meningococcal infection
0.688 0.312 0.000
A37 Whooping cough
0.688 0.312 0.000
A36 Diphtheria
0.688 0.312 0.000
A32 Listeriosis
0.688 0.312 0.000
A31 Infection due to other mycobacteria
0.688 0.312 0.000
A30 Leprosy [Hansen's disease]
0.688 0.312 0.000
A46 Erysipelas
0.688 0.312 0.000
A38 Scarlet fever
0.688 0.312 0.000
A35 Other tetanus
0.688 0.312 0.000
A34 Obstetrical tetanus
0.688 0.312 0.000
A33 Tetanus neonatorum
0.688 0.312 0.000
N81.0 Female urethrocele
0.688 0.312 0.000
C18.4 Transverse colon
0.687 0.313 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.686 0.313 0.000
C17 Malignant neoplasm of small intestine
0.686 0.313 0.000
C23 Malignant neoplasm of gallbladder
0.686 0.313 0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
0.686 0.314 0.000
D74 Methaemoglobinaemia
0.686 0.314 0.000
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere
0.686 0.314 0.000
D71 Functional disorders of polymorphonuclear neutrophils
0.686 0.314 0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract
0.686 0.314 0.000
N70 Salpingitis and oophoritis
0.686 0.314 0.000
N92.2 Excessive menstruation at puberty
0.685 0.314 0.000
G55.0 Nerve root and plexus compressions in neoplastic disease
0.686 0.314 0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances
0.684 0.316 0.000
F18 Mental and behavioural disorders due to use of volatile solvents
0.684 0.316 0.000
F16 Mental and behavioural disorders due to use of hallucinogens
0.684 0.316 0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine
0.684 0.316 0.000
F14 Mental and behavioural disorders due to use of cocaine
0.684 0.316 0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics
0.684 0.316 0.000
F11 Mental and behavioural disorders due to use of opioids
0.684 0.316 0.000
M70-M79 Other soft tissue disorders
0.684 0.316 0.000
C90.3 Solitary plasmacytoma
0.684 0.316 0.000
C90.1 Plasma cell leukaemia
0.684 0.316 0.000
N83.1 Corpus luteum cyst
0.682 0.318 0.000
H03 Disorders of eyelid in diseases classified elsewhere
0.682 0.318 0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.681 0.318 0.000
H10-H13 Disorders of conjunctiva
0.681 0.319 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.681 0.319 0.000
Y43.1 Antineoplastic antimetabolites
0.680 0.320 0.000
D69.3 Idiopathic thrombocytopenic purpura
0.680 0.320 0.000
F17.9 Unspecified mental and behavioural disorder
0.679 0.321 0.000
F17.8 Other mental and behavioural disorders
0.679 0.321 0.000
F17.7 Residual and late-onset psychotic disorder
0.679 0.321 0.000
F17.6 Amnesic syndrome
0.679 0.321 0.000
F17.5 Psychotic disorder
0.679 0.321 0.000
F17.4 Withdrawal state with delirium
0.679 0.321 0.000
F17.3 Withdrawal state
0.679 0.321 0.000
F17.0 Acute intoxication
0.679 0.321 0.000
H05.2 Exophthalmic conditions
0.678 0.322 0.000
C92 Myeloid leukaemia
0.678 0.322 0.000
F33 Recurrent depressive disorder
0.677 0.323 0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified
0.676 0.324 0.000
C02 Malignant neoplasm of other and unspecified parts of tongue
0.676 0.324 0.000
N11 Chronic tubulo-interstitial nephritis
0.675 0.325 0.000
H43 Disorders of vitreous body
0.674 0.326 0.000
C32.9 Larynx, unspecified
0.674 0.326 0.000
A41.4 Septicaemia due to anaerobes
0.674 0.326 0.000
A41.3 Septicaemia due to Haemophilus influenzae
0.674 0.326 0.000
A41.2 Septicaemia due to unspecified staphylococcus
0.674 0.326 0.000
X60-X84 Intentional self-harm
0.672 0.327 0.000
H04.9 Disorder of lachrymal system, unspecified
0.672 0.328 0.000
H04.8 Other disorders of lachrymal system
0.672 0.328 0.000
H04.6 Other changes in lachrymal passages
0.672 0.328 0.000
H04.4 Chronic inflammation of lachrymal passages
0.672 0.328 0.000
H04.0 Dacryoadenitis
0.672 0.328 0.000
H01 Other inflammation of eyelid
0.671 0.329 0.000
M00-M03 Infectious arthropathies
0.669 0.331 0.000
J47 Bronchiectasis
0.669 0.331 0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes
0.669 0.331 0.000
H55-H59 Other disorders of eye and adnexa
0.668 0.332 0.000
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere
0.667 0.333 0.000
N76 Other inflammation of vagina and vulva
0.667 0.333 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.666 0.334 0.000
N92.1 Excessive and frequent menstruation with irregular cycle
0.665 0.335 0.000
D68.6 Other Thrombophilia
0.664 0.336 0.000
N17 Acute renal failure
0.664 0.336 0.000
C15 Malignant neoplasm of oesophagus
0.664 0.336 0.000
M41 Scoliosis
0.664 0.336 0.000
A41.0 Septicaemia due to Staphylococcus aureus
0.663 0.336 0.000
D67 Hereditary factor IX deficiency
0.663 0.337 0.000
D66 Hereditary factor VIII deficiency
0.663 0.337 0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]
0.663 0.337 0.000
Y35-Y36 Legal intervention and operations of war
0.663 0.337 0.000
Y10-Y34 Event of undetermined intent
0.663 0.337 0.000
Y00-Y09 Assault
0.663 0.337 0.000
X85-X99 Assault
0.663 0.337 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.663 0.337 0.000
X50-X57 Overexertion, travel and privation
0.663 0.337 0.000
X30-X39 Exposure to forces of nature
0.663 0.337 0.000
X20-X29 Contact with venomous animals and plants
0.663 0.337 0.000
X10-X19 Contact with heat and hot substances
0.663 0.337 0.000
X00-X09 Exposure to smoke, fire and flames
0.663 0.337 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.663 0.337 0.000
W75-W84 Other accidental threats to breathing
0.663 0.337 0.000
W65-W74 Accidental drowning and submersion
0.663 0.337 0.000
V98-V99 Other and unspecified transport accidents
0.663 0.337 0.000
V95-V97 Air and space transport accidents
0.663 0.337 0.000
V90-V94 Water transport accidents
0.663 0.337 0.000
V80-V89 Other land transport accidents
0.663 0.337 0.000
V70-V79 Bus occupant injured in transport accident
0.663 0.337 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.663 0.337 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.663 0.337 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.663 0.337 0.000
V01-V09 Pedestrian injured in transport accident
0.663 0.337 0.000
B48 Other mycoses, not elsewhere classified
0.661 0.338 0.000
B47 Mycetoma
0.661 0.338 0.000
B46 Zygomycosis
0.661 0.338 0.000
B45 Cryptococcosis
0.661 0.338 0.000
B44 Aspergillosis
0.661 0.338 0.000
B43 Chromomycosis and phaeomycotic abscess
0.661 0.338 0.000
B42 Sporotrichosis
0.661 0.338 0.000
B41 Paracoccidioidomycosis
0.661 0.338 0.000
B40 Blastomycosis
0.661 0.338 0.000
B39 Histoplasmosis
0.661 0.338 0.000
B38 Coccidioidomycosis
0.661 0.338 0.000
B36 Other superficial mycoses
0.661 0.338 0.000
B49 Unspecified mycosis
0.661 0.338 0.000
N41 Inflammatory diseases of prostate
0.661 0.339 0.000
M65.34 Trigger finger-Hand
0.661 0.339 0.000
C48.2 Peritoneum, unspecified
0.659 0.341 0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
0.659 0.341 0.000
C46 Kaposi's sarcoma
0.659 0.341 0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.658 0.342 0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges
0.658 0.342 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.658 0.342 0.000
M96 Postprocedural musculoskeletal disorders, not elsewhere classified
0.658 0.342 0.000
N64.1 Fat necrosis of breast
0.657 0.343 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.657 0.343 0.000
Y59 Other and unspecified vaccines and biological substances
0.657 0.343 0.000
Y58 Bacterial vaccines
0.657 0.343 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.657 0.343 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.657 0.343 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.657 0.343 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.657 0.343 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.657 0.343 0.000
Y48 Anaesthetics and therapeutic gases
0.657 0.343 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.657 0.343 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.657 0.343 0.000
Y44 Agents primarily affecting blood constituents
0.657 0.343 0.000
G81.9 Hemiplegia, unspecified
0.656 0.344 0.000
N71 Inflammatory disease of uterus, except cervix
0.656 0.344 0.000
C18.5 Splenic flexure
0.655 0.344 0.000
Y40 Systemic antibiotics
0.655 0.345 0.000
N81.3 Complete uterovaginal prolapse
0.655 0.345 0.000
Q80-Q89 Other congenital malformations
0.655 0.345 0.000
G30 Alzheimer's disease
0.654 0.346 0.000
D73 Diseases of spleen
0.654 0.346 0.000
N89.5 Stricture and atresia of vagina
0.654 0.346 0.000
D69.5 Secondary thrombocytopenia
0.654 0.346 0.000
D47.3 Essential (haemorrhagic) thrombocythaemia
0.652 0.347 0.000
C79.2 Secondary malignant neoplasm of skin
0.652 0.348 0.000
G12 Spinal muscular atrophy and related syndromes
0.651 0.349 0.000
N89.8 Other specified noninflammatory disorders of vagina
0.651 0.349 0.000
C18.8 Overlapping lesion of colon
0.651 0.349 0.000
M65.9 Synovitis and tenosynovitis, unspecified
0.651 0.349 0.000
M45 Ankylosing spondylitis
0.650 0.349 0.000
C18.3 Hepatic flexure
0.650 0.350 0.000
M86-M90 Other osteopathies
0.650 0.350 0.000
C77.0 Lymph nodes of head, face and neck
0.649 0.351 0.000
G83 Other paralytic syndromes
0.646 0.354 0.000
J98.8 Other specified respiratory disorders
0.646 0.354 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.645 0.355 0.000
N18.5 Chronic kidney disease, stage 5
0.645 0.355 0.000
C91 Lymphoid leukaemia
0.645 0.355 0.000
D47.1 Chronic myeloproliferative disease
0.644 0.356 0.000
M91-M94 Chondropathies
0.642 0.358 0.000
N99-N99 Other disorders of the genitourinary system
0.641 0.359 0.000
H20 Iridocyclitis
0.640 0.360 0.000
J70 Respiratory conditions due to other external agents
0.640 0.360 0.000
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours
0.640 0.360 0.000
J67 Hypersensitivity pneumonitis due to organic dust
0.640 0.360 0.000
J66 Airway disease due to specific organic dust
0.640 0.360 0.000
J63 Pneumoconiosis due to other inorganic dusts
0.640 0.360 0.000
J62 Pneumoconiosis due to dust containing silica
0.640 0.360 0.000
J65 Pneumoconiosis associated with tuberculosis
0.640 0.360 0.000
J64 Unspecified pneumoconiosis
0.640 0.360 0.000
J60 Coalworker's pneumoconiosis
0.640 0.360 0.000
M20-M25 Other joint disorders
0.640 0.360 0.000
G70-G73 Diseases of myoneural junction and muscle
0.639 0.361 0.000
Y52 Agents primarily affecting the cardiovascular system
0.639 0.361 0.000
M47 Spondylosis
0.638 0.361 0.000
N03 Chronic nephritic syndrome
0.638 0.362 0.000
G25.8 Other specified extrapyramidal and movement disorders
0.638 0.362 0.000
H05.0 Acute inflammation of orbit
0.637 0.363 0.000
D75.1 Secondary polycythaemia
0.636 0.363 0.000
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis
0.635 0.365 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2026 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.